Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metolazone - oral solution - 1mg/1ml

Malta - englanti - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - metolazone - tablet - metolazone 5 mg - diuretics

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metolazone - oral tablet - 2.5mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - metolazone - oral tablet - 5mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (canada) - metolazone - oral tablet - 5mg

Kanada - englanti - Health Canada

aventis pharma inc - metolazone - tablet - 5mg - metolazone 5mg - thiazide-like diuretics

Kanada - englanti - Health Canada

sanofi-aventis canada inc - metolazone - tablet - 2.5mg - metolazone 2.5mg - thiazide-like diuretics

Kenia - englanti - Pharmacy and Poisons Board

centaur pharmaceuticals pvt. ltd. centaur house near grand hyatt vakola santacruz - metolazone - tablet - metolazone 5mg - low-ceiling diuretics excluding thiazides: plain

Filippiinit - englanti - FDA (Food And Drug Administration)

dega international pharma corp.; distributor: dega international pharma corp. - metolazone - tablet - 5 mg

Yhdysvallat - englanti - NLM (National Library of Medicine)

celltech pharmaceuticals, inc. - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - tablet - 500 ug - mykrox tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets have not been evaluated for the treatment of congestive heart failure or fluid retention due to renal or hepatic disease and the correct dosage for these conditions and other edema states has not been established. since a safe and effective diuretic dose has not been established, mykrox tablets should not be used when diuresis is desired. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia (see precautions). edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. mykrox is not indicated for the treatment of edema in pregnancy. dependent edema in pregnancy resulting